Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT01264640 Active, not recruiting - Healthy Volunteers Clinical Trials

Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma

Start date: July 2010
Phase: N/A
Study type: Interventional

The impact of anti-platelet drugs on the concentrations of Brain-derived neurotrophic factor (BDNF) in human plasma and serum is unknown. It is the aim of this study to investigate the impact of a single dose of Aspirin (500 mg) or Clopdigrel (600 mg) on the concentrations of Brain-derived neurotrophic factor (BDNF) in plasma and serum of healthy volunteers.

NCT ID: NCT01263808 Completed - Healthy Volunteers Clinical Trials

Cardiac Safety of Indacaterol

Start date: April 2008
Phase: Phase 1
Study type: Interventional

This study compares the cardiac safety of inhaled indacaterol with that of placebo and oral moxifloxacin.

NCT ID: NCT01262989 Completed - Healthy Volunteers Clinical Trials

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

Start date: January 2010
Phase: Phase 1
Study type: Interventional

It will be an open-label, randomized, laboratory-blind, crossover study with 02 treatments, 02 sequences, and 02 periods, in which the healthy male volunteers under fasting conditions receive, in each period, the test formulation or the reference formulation

NCT ID: NCT01262794 Completed - Healthy Volunteers Clinical Trials

Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male Subjects

Start date: November 2010
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of CDP6038 following single dose subcutaneous (sc) administration of CDP6038 to Japanese subjects. To evaluate the Pharmacokinetics of CDP6038 following single dose sc administration of CDP6038 to Japanese subjects

NCT ID: NCT01259544 Completed - Healthy Volunteers Clinical Trials

BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency

Start date: January 2009
Phase: Phase 2
Study type: Interventional

13C breath di-peptide tests are an effective non-invasive tool to detect pancreatic exocrine function in patients with Chronic Pancreatitis.

NCT ID: NCT01258777 Completed - Healthy Volunteers Clinical Trials

A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

Start date: October 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics of golimumab in Japanese and Caucasian Males.

NCT ID: NCT01255501 Completed - Healthy Volunteers Clinical Trials

First in Human Study of NI-0701 in Healthy Volunteers

Start date: n/a
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.

NCT ID: NCT01252147 Completed - Healthy Volunteers Clinical Trials

Inter-rater and Intra-rater Reliability Study of the Global Eyelash Assessment Scale for Assessment of Overall Eyelash Prominence

Start date: December 2010
Phase: N/A
Study type: Observational

This study will evaluate the inter-rater and intra-rater reliability of the Global Eyelash Assessment (GEA) scale with photonumeric guide in Japanese subjects.

NCT ID: NCT01250990 Completed - Healthy Volunteers Clinical Trials

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis

ENTHRALL
Start date: November 2010
Phase: N/A
Study type: Interventional

This study looks at whether niacin improves reverse cholesterol transport (RCT) in healthy volunteers. 3H-Cholesterol will be used to measure RCT by analyzing changes in the tracer activity in total plasma, lipoproteins, red blood cells (RBCs) and stool. The hypothesis is that niacin augments reverse cholesterol transport.

NCT ID: NCT01250834 Completed - Healthy Volunteers Clinical Trials

LY2189265 and Atorvastatin Interaction Study

Start date: December 2010
Phase: Phase 1
Study type: Interventional

This study will assess if giving LY2189265 at the same time as atorvastatin affects how the body absorbs atorvastatin.